Skip to main content

Table 1 Clinicopathological correlation of PRO2000/ANCCA expression in HCC

From: Significance of PRO2000/ANCCA expression, a novel proliferation-associated protein in hepatocellular carcinoma

Feature

Cases

PRO2000/ANCCA

P-value

-

+

++

Gender

    

0.697

Male

96

38

46

12

 

Female

11

3

6

2

 

Age (years)

    

0.524

≤51

53

23

23

7

 

>51

54

18

29

7

 

Serum HBsAg

    

0.737

Negative

44

17

20

7

 

Positive

63

24

32

7

 

Serum AFP (ng/ml)

    

0.703

≤20

48

18

25

5

 

>20

59

23

27

9

 

Tumor size (cm)

    

0.107

≤5

55

25

26

4

 

>5

52

16

26

10

 

Tumor number

    

0.003

Single

80

38

32

10

 

Multiple

27

3

20

4

 

Tumor differentiation

    

<0.001

I-II

76

40

34

2

 

III-IV

31

1

18

12

 

Cirrhosis

    

0.519

Negative

51

21

22

8

 

Positive

56

20

30

6

 

TNM stage

    

<0.001

I-II

81

41

38

2

 

III-IV

26

0

14

12

 

Tumor microsatellite

    

0.011

Absent

77

36

31

10

 

Present

30

5

21

4

 

Portal vein tumor thrombus

    

<0.001

Absent

96

41

47

8

 

Present

11

0

5

6

 

Recurrence

    

<0.001

Absent

89

39

43

7

 

Present

18

2

9

7

 
  1. -, negative; +, moderate positive; ++, strong positive. Significant differences are shown in bold.